RecallRadar

FDA Device recall Z-1350-2018

Spinal Jaxx Interbody Fusion Device, Model: 100001-511, Size: 9 H x 10 W x 25 L Product Usage: The Spinal Jaxx interbody fusion device is i…

On 2018-04-18 the FDA classified a Class II recall of Spinal Jaxx Interbody Fusion Device, Model: 100001-511, Size: 9 H x 10 W x 25 L Product Usage: The Spinal Jaxx interbody fusion device is i… by Neuropro Spinal Jaxx, citing the implant size is incorrectly etched on the implant. The size listed on the box is correct.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1350-2018
ClassificationClass II
Statusterminated
Initiated2018-01-18
Published2018-04-18
Last updated2026-09-13 11:54 UTC
CompanyNeuropro Spinal Jaxx
DistributionCA

Product

Spinal Jaxx Interbody Fusion Device, Model: 100001-511, Size: 9 H x 10 W x 25 L Product Usage: The Spinal Jaxx interbody fusion device is indicated for spinal fusion for patients with degenerative disc disease (DDD) at one or two contiguous levels of the lumbosacral spine (L2-S1). DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. Patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). The indicated patient population is skeletally mature patients who have had six (6) months of non-operative treatment. The Spinal Jaxx interbody fusion device must be used with autogenous bone graft material and with supplemental fixation.

Reason

The implant size is incorrectly etched on the implant. The size listed on the box is correct.

Identifiers

code_infoLot 1599, Expiration date: 10/03/2018

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1350-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.